" class="no-js "lang="en-US"> Lunit - Medtech Alert
Sunday, October 01, 2023

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Lunit | Pharmtech Focus

Lunit

About Lunit

Lunit

Lunit, abbreviated from “learning unit,” is a Medical AI software company devoted to developing advanced medical image analytics and novel imaging biomarkers via cutting-edge deep learning technology.

Founded in 2013, Lunit has been internationally acknowledged for its advanced, state-of-the-art technology and its application in medical images. Lunit is based in Seoul, South Korea.

Related Story

News

 Lunit Meets MDR CE Requirements for 3D Breast Tomosynthesis AI Solution | MTA

Lunit Meets MDR CE Requirements for 3D Breast Tomosynthesis AI Solution

March 20 2023

Lunit, a leading global provider of AI-powered cancer solutions, today announced that its AI solution […]

Artificial Intelligence

 Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors | Pharmtech Focus

Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors

November 25 2021

Lunit, a leading medical AI provider, today announced it has raised $61 million in its Pre-IPO fundraising […]

Artificial Intelligence

 AI Startup Lunit Secures Investment from Guardant Health in a Strategic Funding Round | Pharmtech Focus

AI Startup Lunit Secures Investment from Guardant Health in a Strategic Funding Round

July 20 2021

Lunit, a leading AI startup in AI-powered cancer solutions, today announced a strategic investment of […]